Tamsulosin

• Benign Prostatic Hyperplasia (BPH)
• Lower Urinary Tract Symptoms
• Kidney Stones

Tamsulosin is a selective alpha-1A and alpha-1D adrenergic receptor antagonist widely used to treat the urinary symptoms associated with benign prostatic hyperplasia (BPH). It is one of the most commonly prescribed medications for BPH and is also used off-label to facilitate passage of ureteral stones.

Mechanism of Action

Tamsulosin provides symptom relief through selective receptor blockade:

• Alpha-1A receptor antagonism: Relaxes smooth muscle in the prostate and bladder neck
• Alpha-1D receptor antagonism: May contribute to effects on bladder detrusor muscle
• Improved urine flow: Reduces dynamic obstruction without significantly affecting blood pressure
• Selective action: 12 times more selective for alpha-1A vs alpha-1B receptors

This selectivity allows effective symptom relief with less orthostatic hypotension compared to older, non-selective alpha-blockers like terazosin and doxazosin.

Available Formulations

Tamsulosin is available as oral capsules:

• 0.4 mg modified-release capsules (Flomax and generics)

Medical Uses

FDA-Approved Indication:

• Treatment of signs and symptoms of benign prostatic hyperplasia (BPH)

Off-Label Uses:

• Facilitation of ureteral stone passage (medical expulsive therapy)
• Chronic prostatitis/chronic pelvic pain syndrome
• Lower urinary tract symptoms in women (limited evidence)

Dosing Guidelines

Adults (BPH):

• 0.4 mg once daily, approximately 30 minutes after the same meal each day
• May increase to 0.8 mg once daily if inadequate response after 2-4 weeks

Ureteral Stones (off-label):

• 0.4 mg once daily until stone passage or up to 4-6 weeks

Administration:

• Swallow capsules whole; do not crush, chew, or open
• Take 30 minutes after a meal for optimal absorption

Important Safety Information

Contraindications:

• Known hypersensitivity to tamsulosin or any component
• History of tamsulosin-induced angioedema

Warnings and Precautions:

• Orthostatic hypotension: May occur; use caution with antihypertensives
• Intraoperative Floppy Iris Syndrome (IFIS): Observed during cataract and glaucoma surgery; alert ophthalmologist
• Priapism: Rare; requires immediate medical attention
• Prostate cancer: Rule out before treatment
• Sulfa allergy: Tamsulosin contains a sulfonamide group; use with caution in sulfa-allergic patients (cross-reactivity is rare)

Drug Interactions

• CYP3A4 inhibitors (ketoconazole, erythromycin): May increase tamsulosin levels; use with caution
• CYP2D6 inhibitors (paroxetine, fluoxetine, terbinafine): May increase tamsulosin levels
• Strong CYP3A4 inhibitors with CYP2D6 inhibitors: Avoid concurrent use
• Other alpha-blockers: Avoid due to additive effects
• PDE5 inhibitors: Potential additive hypotensive effects; use with caution
• Warfarin: Limited interaction; monitor as a precaution
• Cimetidine: May increase tamsulosin absorption

Special Populations

• Elderly: No dose adjustment; more susceptible to orthostatic hypotension
• Renal Impairment: No adjustment for CrCl >10 mL/min; not studied in severe impairment
• Hepatic Impairment: No adjustment for mild to moderate; not studied in severe impairment
• Women: Not FDA-approved; occasionally used off-label for LUTS
• Pediatric: Safety and efficacy not established